课题基金 / 基金详情

CYTOSTATIC ROLE OF THE ARGININE-NITRIC OXIDE PATHWAY

CYTOSTATIC ROLE OF THE ARGININE-NITRIC OXIDE PATHWAY
精氨酸-一氧化氮途径的细胞抑制作用
批准号:
6389673
负责人:
LOUIS J IGNARRO
金额:
$30.01万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2003-03-31

项目摘要

项目成果

LOUIS J IGNARRO的其他基金

相似基金

相关文献

中文摘要
翻译
一氧化氮(NO)被认为会干扰细胞增殖,
英文摘要
Nitric oxide (NO) is believed to interfere with cell proliferation, although its mechanism of cytostatic action is largely unknown. This view is based on the observations that NO donor agents or induction of NO synthase in cultured cells is associated with the concomitant attenuation of cell proliferation. We have found that N/G-hydroxy-L- arginine (NOHA), an intermediate in the oxidation of arginine to NO + citrulline, is synthesized and released from cells in culture. NOHA is a potent competitive inhibitor or arginase (Ki = 10 muM) and turns off production of ornithine + urea in cells. Ornithine is the precursor to putrescine and other polyamines required for cell proliferation. We have also found that NO inhibits ornithine decarboxylase activity. The principal objective of the proposed research is to determine whether NO synthase, via the biologic actions of NOHA and NO, plays a physiological or pathophysiological role in regulating the growth of vascular smooth muscle cells and tumor cells, and to elucidate the mechanisms by which cell growth is inhibited. The central hypothesis that drives this proposal is that two products of the NO synthase reaction, NOHA and NO, function biologically to slow cell proliferation by inhibiting two sequential enzymatic steps (NOHA inhibits arginase; NO inhibits ornithine decarboxylase) in the pathway leading to the production of polyamines from arginine. These additional cytostatic mechanisms resulting from increased NO synthase activity would complement other known cytostatic mechanisms of NO such as guanylyl cyclase activation and cyclic GMP-mediated impairment of DNA synthesis. The two specific aims that will be taken to rigorously test the proposed hypothesis are: (a) to ascertain the mechanisms by which NOHA, NO and NO synthase activity interfere with cell proliferation under physiological or pathophysiological conditions and (b) to elucidate the mechanism by which NO inhibits ornithine decarboxylase. The proposed research should advance our understanding of the biological role of NO synthase in regulating cell proliferation.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2337/diabetes.53.7.1841
发表时间: 2004-07
期刊: Diabetes
影响因子: 7.7
作者: [D. Sumi;L. Ignarro]
通讯作者: D. Sumi;L. Ignarro
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells.
糖氧化低密度脂蛋白下调人冠状细胞中的内皮一氧化氮合酶。
DOI: 10.1016/s0735-1097(02)02306-9
发表时间: 2002
期刊: Journal of the American College of Cardiology
影响因子: 24
作者: [Napoli,Claudio, Lerman,LilachO, deNigris,Filomena, Loscalzo,Joseph, Ignarro,LouisJ]
通讯作者: Ignarro,LouisJ
Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP.
奈比洛尔通过涉及一氧化氮而非环 GMP 的机制抑制血管平滑肌细胞增殖。
DOI: 10.1016/s1089-8603(02)00113-1
发表时间: 2002
期刊: Nitric oxide : biology and chemistry
影响因子: --
作者: [Ignarro,LouisJ, Sisodia,Manisha, Trinh,Kim, Bedrood,Sahar, Wu,Guoyao, Wei,LiuHua, Buga,GeorgetteM]
通讯作者: Buga,GeorgetteM
Arginase and Nitric Oxide in Atherosclerosis
Arginase and Nitric Oxide in Atherosclerosis
Arginase and Nitric Oxide in Atherosclerosis
Arginase and Nitric Oxide in Atherosclerosis
海外基金